華特氣體(688268.SH):公司的很多產品獲得IC頭部客户的認同
格隆匯6月6日丨有投資者向華特氣體(688268.SH)提問:從市場同行來看,各家都有自己的王牌產品,公司的特氣產品品種很多,目前市場都還在差異化的競爭,但是未來不可避免出現重合的品類比如都在研發的六氟丁二烯,是否意味着未來一兩年市場競爭會更加激烈?
華特氣體回覆:市場化競爭下,這種現象是普遍存在的。在半導體廠尤其是IC領域應用的電子特氣最重要兩個指標就是看產品不純物指標的純度,及其產品的精度,公司在兩個指標的掌握上具有較強的優勢;另外,公司的很多產品獲得IC頭部客户的認同,對於新產品的研發、推出、應用都具有較強的競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.